European medicines regulator recommends approval for Novo's Wegovy pill
22/05/2026 11:44
May 22 (Reuters) - The European Medicines Agency recommended approval for Novo Nordisk's NOVOb.CO weight-loss pill Wegovy, the regulator said on Friday, clearing its path to become the first oral weight loss drug in Europe, ahead of U.S. rival Eli Lilly LLY.N. (Reporting by Kunal Das and Puyaan Singh in Bengaluru) ((Kunal.Das2@thomsonreuters.com;))
Recent news on Eli Lilly and Co
See all newsAntares Therapeutics signs potential $1.9 billion cancer drug deal with Novartis
Absci rises on positive hair-loss drug data
China approval for Eli Lilly GLP-1 pill to come as soon as 2026, executive says
HK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)